PDX-1 Is a Therapeutic Target for Pancreatic Cancer, Insulinoma and Islet Neoplasia Using a Novel RNA Interference Platform
Shi‐He Liu(Baylor College of Medicine), F. Charles Brunicardi(University of California, Los Angeles)
Cited by 27
Related Papers
Smart exosomes enhance PDAC targeted therapy
|Journal of Controlled Release|2024|49